Titre:
  • First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
Auteur:Kim, Tae Won; Burris, Howard H.A.; de Miguel Luken, María José; Pishvaian, Michael M.J.; Bang, Yung Jue; Gordon, Michael; Awada, Ahmad; Camidge, David Ross; Hodi, Frank Stephen; McArthur, Grant A; Miller, Wilson W.H.; Cervantes, Andrés; Chow, Laura Q M LQ; Lesokhin, Alexander A.M.; Rutten, Annemie; Sznol, Mario; Rishipathak, Deepali; Chen, Shang Chiung; Stefanich, Eric; Pourmohamad, Tony; Anderson, Maria; Kim, Jeong; Huseni, Mahrukh; Rhee, Ina; Siu, Lillian Lai Yun L.L.
Informations sur la publication:Clinical cancer research, 28, 16, page (3452-3463)
Statut de publication:Publié, 2022-08
Sujet CREF:Cancérologie
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1078-0432
info:doi/10.1158/1078-0432.CCR-21-4020
info:scp/85136956244